A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Sjogrens Disease

In brief

The purpose of this study is to evaluate the efficacy of abatacept compared to placebo in patients with Sjögren's Syndrome.

Key facts

Study ID
NCT02915159
Run by
Bristol-Myers Squibb
People needed
250
Starts
2016-12-06
Expected to finish
2019-07-23
Last updated by the study team
2020-08-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.